Skip to main content
Hanmi Science Co.,Ltd logo

Hanmi Science Co.,Ltd — Investor Relations & Filings

Ticker · 008930 ISIN · KR7008930000 KO Manufacturing
Open in API
Filings indexed 698 across all filing types
Latest filing 2026-01-28 M&A Activity
Country KR South Korea
Listing KO 008930

About Hanmi Science Co.,Ltd

https://www.hanmipharm.com/

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결(자회사의 주요경영사항)
M&A Activity Classification · 95% confidence The document is a regulatory filing from Hanmi Science regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) for the export of pharmaceutical products to Mexico. This type of disclosure, which details a specific business contract, does not fit into categories like financial reports, dividends, or management changes. It is a standard regulatory disclosure of a material business event, which falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate announcements.
2026-01-28 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Hanmi Science regarding a subsidiary's (Hanmi Pharmaceutical) clinical trial approval for a diabetes drug (HM11260C) by the Ministry of Food and Drug Safety (MFDS). It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean stock market (KRX). Since it does not fit into specific categories like M&A, dividends, or share repurchases, and is a formal regulatory disclosure of a material event, it is classified as a Regulatory Filing (RNS).
2026-01-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is the standard Korean regulatory filing for disclosing significant changes in share ownership (often referred to as the 5% rule filing). It details the reporting person (Song Young-sook), special related parties, changes in share counts, and the purpose of holding (influence on management). This fits the 'Major Shareholding Notification' category.
2026-01-14 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서(자기주식 처분 결정)' (Major Report: Decision on Disposal of Treasury Shares) submitted to the Financial Supervisory Service/Korea Exchange. It details the company's decision to dispose of its own shares for employee performance incentives. According to the filing definitions, 'Transaction in Own Shares' (POS) is the correct category for reports regarding a company buying back or selling/disposing of its own shares.
2026-01-09 Korean
주요사항보고서(자기주식처분결정)(자회사의 주요경영사항)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Management Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange. It specifically details a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정) for the purpose of employee stock-based compensation (RSA). According to the provided definitions, the category 'Transaction in Own Shares' (POS) covers reports of a company buying back or selling its own shares, which aligns perfectly with this filing.
2026-01-09 Korean
주요사항보고서(자기주식처분결정)(자회사의 주요경영사항)
Transaction in Own Shares Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서' (Major Matters Report) regarding the '자기주식 처분 결정' (Decision to Dispose of Treasury Shares). It details the number of shares to be disposed of, the purpose (employee productivity bonus), the method, and the impact on share value. This falls under the category of a company reporting the disposal or transaction of its own shares, which corresponds to the 'Transaction in Own Shares' (POS) category.
2026-01-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.